Associate Director, Medical Writing

Salary Range: $194,841.00 To $222,985.00 Annually

About BlossomHill Therapeutics:

BlossomHill Therapeutics, Inc. is a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to develop innovative small molecule medicines which address significant unmet medical needs in cancer treatment. Founded and led by industry veteran J. Jean Cui, Ph.D., with her proven track record in oncology drug design and development – including three FDA-approved drugs – BlossomHill applies cutting-edge science to address key oncogenic drivers and improve patient outcomes in difficult-to-treat cancers. The company’s lead clinical programs include BH-30643, a first-in-class, macrocyclic, non-covalent, mutant-selective OMNI-EGFRTM inhibitor for the treatment of EGFR-mutated non-small cell lung cancer, BH-30236, a macrocyclic CLK inhibitor for the treatment of relapsed or refractory acute myeloid leukemia or higher-risk myelodysplastic syndrome and BH-501284, a non-covalent, pan-KRAS inhibitor for treatment of diverse KRAS-mutant tumors.

BlossomHill Therapeutics is seeking an Associate Director, Medical Writing, reporting to the Senior Director, Medical Writing, to work with cross-functional teams to develop, write, and review clinical and regulatory documents, ensuring that all documents are of high quality and comply with internal and external standards.

Key Responsibilities:

• Serve as lead medical writer for assigned studies and programs, planning, preparing, writing, editing, formatting, and finalizing non‑clinical, clinical, and regulatory documents. Documents may include: INDs, CTAs, non‑clinical summaries, clinical protocols, clinical study reports, Investigator Brochures, updates to regulatory submissions, briefing books, annual reports/DSURs, manuscripts, and posters.
• Implement activities related to the preparation of defined documents (storyline development, authoring, facilitating review and approval, and final formatting), ensuring documents meet regulatory and internal standards.
• Coordinate and oversee external medical writing vendors for assigned projects, ensuring delivery against agreed scope, timelines, and quality; elevate vendor performance issues to the Senior Director, Medical Writing as needed.
• Partner with Regulatory Affairs and cross-functional subject matter experts to organize and prepare documents for regulatory health authority submissions, contributing to document strategy, structure, and key messages while aligning with overall program plans set by the Senior Director.
• Represent Medical Writing on project and study teams for assigned programs, advising teams on content and format requirements for key documents and coordinating writing activities (eg, timelines, review cycles, and revision responsibilities).
• Contribute to the development and refinement of templates, style guidelines, and SOPs for clinical and regulatory documentation; may lead specific template or process improvement workstreams under the direction of the Senior Director.
• Ensure final documents adhere to standard operating procedures (SOPs), good clinical practice (GCP), and International Council on Harmonization (ICH) requirements, and support inspection‑readiness of assigned documents and activities.
• Collaborate effectively with Research & Development colleagues, including clinical research, regulatory, safety, biostatistics, clinical operations, translational medicine, and discovery, to ensure alignment and accuracy of clinical and regulatory content.
• Provide guidance and informal mentoring to junior writers and contractors on assigned projects, promoting best practices in medical writing, while formal line management responsibility remains with the Senior Director.
• Provide input to the Senior Director, Medical Writing on operational improvements, tools, and processes to enhance efficiency and quality of deliverables within the Medical Writing function.

Qualifications

• Bachelor’s degree in a scientific, healthcare, or related discipline; advanced degree (Master’s or PhD) preferred.
• Approximately 8–12 years of relevant medical writing experience in the pharmaceutical, biotechnology, or CRO setting, including substantial experience authoring clinical and regulatory documents such as protocols, CSRs, IBs, and components of IND/CTA/CTA‑equivalent submissions.
• Experience in oncology therapeutic areas (solid tumor and/or hematologic malignancies) strongly preferred.
• Demonstrated ability to interpret and present clinical and non‑clinical data objectively in a clear, concise, and coherent format tailored to regulatory and clinical audiences.
• Excellent organizational and project management skills, with a proven track record of planning, prioritizing, and delivering multiple concurrent writing projects to high standards and tight timelines.
• Ability to work effectively in a team environment, with excellent interpersonal and communication skills to collaborate across levels and functions and with CROs and external consultants.
• Strong technical skills with common software tools (eg, word processing, spreadsheets, document management systems, and online research), including submission‑ready formatting and familiarity with electronic document workflows.
• Excellent oral and written communication skills to effectively interface with internal and external stakeholders.
• Ability to think strategically about document purpose, audience, and messaging, while executing hands‑on writing and driving timelines to completion.
• Proven ability to work effectively with cross-functional teams in a matrix environment and to influence without formal authority.
• Entrepreneurial and passionate; enjoys working in a fast‑paced, small‑company environment and is comfortable operating with limited infrastructure.
• Proactively seeks out, recommends, and implements process and template improvements within the scope of assigned projects.

The company provides equal employment opportunities to all employees and applicants for employment and prohibits discrimination and harassment of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by federal, state, or local laws.

This policy applies to all terms and conditions of employment, including recruiting, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation, and training.

Recruiters and Agencies:

BlossomHill Therapeutics does not accept unsolicited referrals or resumes from any source other than directly from candidates. We will not consider unsolicited referrals and/or resumes from vendors including and without limitation, search firms, staffing agencies, fee-based referral services and recruiting agencies. The submission of referrals or resumes by anyone other than a candidate directly to BlossomHill employees is strictly prohibited. Unsolicited referrals and resumes sent to BlossomHill Therapeutics are deemed gratuitous, and the company will not be obligated or bound in any way to pay any referral or other fee if a person referred to us from a source other than a candidate is hired.

E-Verify:

BlossomHill Therapeutics participates in E-Verify and will provide the federal government with your Form I-9 information to confirm that you are authorized to work in the U.S. If E-Verify cannot confirm that you are authorized to work, this employer is required to give you written instructions and an opportunity to contact the Department of Homeland Security (DHS) or Social Security Administration (SSA) to resolve the issue.